HYDERABAD – June 2, 2023 –Viatris Inc(NASDAQ: VTRS), a global healthcare company, has announced that Viatris India was ranked number 9 in the 2023 LinkedIn Top Companies List. Viatris, the only pharma company to feature among the top 25 companies, was named for its commitment to providing its employees with a supportive and dynamic workplace that fosters career growth and development. The recognition highlights that the company culture is built on a foundation of inclusivity and diversity, and it strives to empower its employees to reach their full potential.
LinkedIn’s 2023 Top Companies annual list put out by LinkedIn News is based on eight pillars, each of which reveals an important element of career progression: the ability to advance, skills growth, company stability, external opportunity, company affinity, gender diversity, educational background, and employee presence in the country. Viatris India enables employees’ career progression as per LinkedIn’s data pertaining to all the pillars, making it a standout employer in India’s competitive job market.
A carefully weighted methodology, using exclusive LinkedIn data analyzing the career paths of millions of global professionals, determines the ranking. The Top Companies list is created with the goal of providing a go-to resource at every stage of one’s career journey.
Commenting on the recognition, Udbhav Ganjoo, Head of HR – Global Operations India Emerging Asia & Access Markets, said, “We are thrilled to be featured in LinkedIn’s Top Companies 2023 list. We believe our greatest asset is our workforce and we strive to create a conducive environment that provides opportunities for personal and professional growth. This distinction is a testimonial to the effort and commitment of our employees and our corporate culture driven by our employees’ passion for learning and growth. We will continue to invest in our employees and provide them with the support and resources they need to thrive in their careers.”
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company empowering people worldwide to live healthier at every stage of life. We provide access to medicines, advance sustainable operations, develop innovative solutions and leverage our collective expertise to connect more people to more products and services through our one-of-a-kind Global Healthcare Gateway®. Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris’ portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognized brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. With more than 38,000 colleagues globally, Viatris is headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on Twitter, LinkedIn, Instagram and YouTube.